Human Proximal Tubular Epithelium Actively Secretes but Does Not Retain Rosuvastatin
Authors:
- Anja VerhulstAVAnja Verhulst
- Rachel SayerRSRachel Sayer
- Marc E. De BroeMBMarc E. De Broe
- Patrick C. D’haesePDPatrick C. D’haese
- Colin D. A. BrownCBColin D. A. Brown
Open Access
- 1 October 2008
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 74 (4) , 1084-1091
Abstract
Rosuvastatin is a potent HMG-CoA reductase inhibitor that has proven to be effective in the treatment of dyslipidemia. Rosuvastatin is cleared from the body by both biliary and renal clearance, the latter believed to be due to active tubular secretion. Whereas the mechanisms of hepatic clearance of rosuvastatin are well documented, those of renal clearance are not. Because rosuvastatin (and other statins) may alter proximal tubular function, this study aimed to characterize the mechanisms of tubular rosuvastatin secretion to define the factors that could influence the presence/concentration of rosuvastatin in proximal tubular cells. Hereto, polarized monolayers of primary human tubular cells were used. We found rosuvastatin net secretion across proximal tubule cells, which was saturable (K50 = 20.4 ± 4.1 μM). The basolateral uptake step was rate-limiting and mediated by OAT3. Rosuvastatin efflux at the apical membrane was mediated by MRP2/4 and ABCG2 together with a small contribution from MDR1 or P-glycoprotein. These data, obtained in an intact human tubule cell model, provide a detailed insight into rosuvastatin's renal handling and the possible factors influencing it.Keywords
This publication has 36 references indexed in Scilit:
- Biliary secretion of rosuvastatin and bile acids in humans during the absorption phaseEuropean Journal of Pharmaceutical Sciences, 2006
- Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine–sirolimus interactionKidney International, 2006
- Drug and Bile Acid Transporters in Rosuvastatin Hepatic Uptake: Function, Expression, and PharmacogeneticsGastroenterology, 2006
- ATP-DEPENDENT TRANSPORT OF ROSUVASTATIN IN MEMBRANE VESICLES EXPRESSING BREAST CANCER RESISTANCE PROTEINDrug Metabolism and Disposition, 2006
- Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environmentClinical Pharmacology & Therapeutics, 2005
- Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteersClinical Therapeutics, 2003
- Flow cytometric immunodissection of the human distal tubule and cortical collecting duct systemKidney International, 2001
- Clinical Pharmacokinetics of PravastatinClinical Pharmacokinetics, 2000
- Cellular and molecular aspects of drug transport in the kidneyKidney International, 2000
- Flow Cytometric Immunodissection of the Human Nephron in vivo and in vitroNephron Experimental Nephrology, 1999